In vivo toxicity evaluation of gold-dendrimer composite nanodevices with different surface charges

References

• Arvizo RR, Miranda OR, Moyano DF, Walden CA, Giri K, Bhattacharya R, 2011. Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles. PLoS One 6:e24374.
   PubMed Web of Science ®Google Scholar
• Balogh LP, Khan MK. 2007. Dendrimer nanocomposites for cancer therapy. Boca Raton, FL: CRC Press - Taylor & Francis Group.
   Google Scholar
• Balogh L, Nigavekar SS, Nair BM, Lesniak W, Zhang C, Sung LY, 2007. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomedicine 3:281–296.
   PubMed Web of Science ®Google Scholar
• Balogh L, Valluzzi R, Laverdure KS, Gido SP, Hagnauer GL, Tomalia DA. 1999. Formation of silver and gold dendrimer nanocomposites. J Nanopart Res 1:353–368.
   Web of Science ®Google Scholar
• Bar-Ilan O, Albrecht RM, Fako VE, Furgeson DY. 2009. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small 5:1897–1910.
   PubMed Web of Science ®Google Scholar
• Bielawski K, Bielawska A, Muszynska A, Poplawska B, Czarnomysy R. 2011. Cytotoxic activity of G3 PAMAM-NH(2) dendrimer-chlorambucil conjugate in human breast cancer cells. Environ Toxicol Pharmacol 32:364–372.
   PubMed Web of Science ®Google Scholar
• Bielinska A, Eichman JD, Lee I, Baker JR Jr, Balogh L. 2002. Imaging {Au0-PAMAM} gold-dendrimer nanocomposites in cells. J Nanopart Res 4:395–403.
   Web of Science ®Google Scholar
• Bouwmeester H, Lynch I, Marvin HJ, Dawon KA, Berges M, Braguer D, 2011. Minimal analytical characterization of. engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology 5:1–11.
   PubMed Web of Science ®Google Scholar
• Daftarian P, Kaifer AE, Li W, Blomberg BB, Frasca D, Roth F, 2011. Peptide-conjugated PAMAM dendrimer as a universal platform for antigen presenting cell targeting and effective DNA-based vaccinations. Cancer Res 71:7452–62.
   PubMed Web of Science ®Google Scholar
• Degeorge JJ, Ahn CH, Andrews PA, Brower ME, Giorgio DW, Goheer MA, 1998. Regulatory considerations for preclinical development of anticancer drugs. Cancer Chemother Pharmacol 41:173–185.
   PubMed Web of Science ®Google Scholar
• Duncan R, Izzo L. 2005. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57:2215–2237.
   PubMed Web of Science ®Google Scholar
• Gaspar R, Duncan R. 2009. Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics. Adv Drug Deliv Rev 61:1220–1231.
   PubMed Web of Science ®Google Scholar
• Greish K, Thiagarajan G, Herd H, Price R, Bauer H, Hubbard D, 2011. Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles. Nanotoxicology; Epub ahead of print.
   PubMedGoogle Scholar
• Gulumian M, Vallyathan V. 2010. Nanoparticles and potential human health implications: past and future directions. Preface. J Toxicol Environ Health A 73:339–340.
   PubMed Web of Science ®Google Scholar
• Hagens WI, Oomen AG, De Jong WH, Cassee FRA, Sips AJ. 2007. What do we need to know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol 49:217–219.
   PubMed Web of Science ®Google Scholar
• Hong S, Leroueil PR, Janus EK, Peters JL, Kober MM, Islam MT, 2006. Interaction of polycationic polymers with supported lipid bilayers and cells: Nanoscale hole formation and enhanced membrane permeability. Bioconjug Chem 17:728–734.
   PubMed Web of Science ®Google Scholar
• Jevprasesphant R, Penny J, Jalal R, Attwood D, Mckeown NB, D'emanuele A. 2003. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm 252:263–266.
   PubMed Web of Science ®Google Scholar
• Khan MK, Nigavekar SS, Minc LD, Kariapper MST, Nair BM, Lesniak WG, 2005. In vivo biodistribution of dendrimers and dendrimer nanocomposites - Implications for cancer imaging and therapy. Technol Cancer Res Treat 4:603–613.
   PubMed Web of Science ®Google Scholar
• King Heiden TC, Dengler E, Kao WJ, Heideman W, Peterson RE. 2007. Developmental toxicity of low generation PAMAM dendrimers in zebrafish. Toxicol Appl Pharmacol 225:70–79.
   PubMed Web of Science ®Google Scholar
• Kolhatkar RB, Kitchens KM, Swaan PW, Ghandehari H. 2007. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjug Chem 18:2054–2060.
   PubMed Web of Science ®Google Scholar
• Kukowska-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP, 2005. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res 65:5317–5324.
   PubMed Web of Science ®Google Scholar
• Lee JH, Cha KE, Kim MS, Hong HW, Chung DJ, Ryu G, 2009. Nanosized polyamidoamine (PAMAM) dendrimer-induced apoptosis mediated by mitochondrial dysfunction. Toxicol Lett 190:202–207.
   PubMed Web of Science ®Google Scholar
• Lesniak WG, Kariapper MST, Nair BM, Tan W, Hutson A, Balogh LP, 2007. Synthesis and characterization of PAMAM dendrimer-based multifunctional nanodevices for targeting αvβ3 integrins. Bioconjug Chem 18:1148–1154.
   PubMed Web of Science ®Google Scholar
• Li C, Liu H, Sun Y, Wang H, Guo F, Rao S, 2009. PAMAM dendrimer nanoparticles promote acute lung injury by inducing autophagic cell death through Akt-TSC2-mTOR signaling pathway. J Mol Cell Biol 1:37–45.
   PubMed Web of Science ®Google Scholar
• Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, 2000. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release 65:133–148.
   PubMed Web of Science ®Google Scholar
• Mcneil SE. 2005. Nanotechnology for the biologist. J Leukoc Biol 78:585–594.
   PubMed Web of Science ®Google Scholar
• Miyano T, Wijagkanalan W, Kawakami S, Yamashita F, Hashida M. 2010. Anionic amino acid dendrimer-trastuzumab conjugates for specific internalization in HER2-positive cancer cells. Mol Pharm 7:1318–1327.
   PubMed Web of Science ®Google Scholar
• Myc A, Majoros IJ, Thomas TP, Baker JR Jr. 2007. Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells. Biomacromolecules 8:13–18.
   PubMed Web of Science ®Google Scholar
• Nair BM, Kariapper MST, Lesniak WG, Tan W, Hutson A, Khan MK, 2009. Toxicity evaluation of gold-dendrimer composite nanodevices in vitro: difference found between tumour and proliferating endothelial cells. Nanotoxicology 3:1743–5404.
   Google Scholar
• Nigavekar SS, Sung LY, Llanes M, El-Jawahri A, Lawrence TS, Becker CW, 2004. 3H dendrimer nanoparticle organ/tumor distribution. Pharm Res 21:476–483.
   PubMed Web of Science ®Google Scholar
• Oberdorster G, Stone V, Donaldson K. 2007. Toxicology of nanoparticles: a historical perspective. Nanotoxicology 1:2–25.
   Web of Science ®Google Scholar
• Research L. 2007. The Nanotech Report. 5th ed. New York: Lux Research.
   Google Scholar
• Rittner K, Benavente A, Bompard-Sorlet A, Heitz F, Divita G, Brasseur R, 2002. New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol Ther 5:104–114.
   PubMed Web of Science ®Google Scholar
• Riveragil P, Oberdorster G, Elder A, Puntes V, Parak WJ. 2010. Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. ACS Nano 4:5527–5531.
   PubMedGoogle Scholar
• Roberts JC, Bhalgat MK, Zera RT. 1996. Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J Biomed Mater Res 30:53–65.
   PubMed Web of Science ®Google Scholar
• Sanhai WR, Sakamoto JH, Canady R, Ferrari M. 2008. Seven Challenges for Nanomedicine. Nat Nanotechnol 3:242–244.
   PubMed Web of Science ®Google Scholar
• Seib FP, Jones AT, Duncan R. 2007. Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells. J Control Release 117:291–300.
   PubMed Web of Science ®Google Scholar
• Shi X, Wang S, Meshinchi S, Van Antwerp ME, Bi X, Lee I, 2007. Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. Small 3:1245–1252.
   PubMed Web of Science ®Google Scholar
• Shukla R, Thomas TP, Peters JL, Desai AM, Kukowska-Latallo J, Patri AK, 2006. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb. Bioconjug Chem 17:1109–1115.
   PubMed Web of Science ®Google Scholar
• Sonavane G, Tomoda K, Makino K. 2008. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces 66:274–280.
   PubMed Web of Science ®Google Scholar
• Thomas TP, Majoros IJ, Kotlyar A, Kukowska-Latallo JF, Bielinska A, Myc A & 2005. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J Med Chem 48:3729–3735.
   PubMed Web of Science ®Google Scholar
• Van Zwieter MJ, Hollander CF. 1985. Monographs on the Pathology of Laboratory Animals : Digestive Systems. Berlin: Springer-Verlag.
   Google Scholar
• Wang J Xia J. 2011. Preferential binding of a novel polyhistidine peptide dendrimer ligand on quantum dots probed by capillary electrophoresis. Anal Chem 83:6323–6329.
   PubMedGoogle Scholar
• Xu R, Wang Y, Wang X, Jeong EK, Parker DL, Lu ZR. 2007. In vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent. Exp Biol Med 232:1081–1089.
   Google Scholar
• Zhao J, Castranova V. 2011. Toxicology of nanomaterials used in nanomedicine. J Toxicol Environ Health B Crit Rev 14:593–632.
   PubMed Web of Science ®Google Scholar
• Zhu W, Okollie B, Bhujwalla ZM, Artemov D. 2008a. PAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approach. Magn Reson Med 59:679–685.
   PubMedGoogle Scholar
• Zhu X, Zhu L, Duan Z, Qi R, Li Y, Lang Y. 2008b. Comparative toxicity of several metal oxide nanoparticle aqueous suspensions to Zebrafish (Danio rerio) early developmental stage. J Environ Sci Health A Tox Hazard Subst Environ Eng 43:278–284.
   PubMed Web of Science ®Google Scholar